Dear all
Wondering if anyone has had any experience with the oncology division at CDER with using real world evidence as a control arm for a pivotal study which would lead to approval. I know this is quite specific, but it would be good to hear thoughts and experience with this from any regulatory colleague.
Thanks
------------------------------
Yasameen Qazen
Sr. Director Head of Regulatory Affairs
Menlo Park
United States
------------------------------